SQD.H — SQI Diagnostics Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -629.63% | ||
Financial Summary
| Year End 30th Sep | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 1.33 | 1.89 | 1.02 | 0.92 | 8.1 | n/a | n/a | 52.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.
Directors
- Clive Beddoe CEO (73)
- Eric Brouwer CSO
- Andrew Morris DRC
- Gerald Connor IND (75)
- Wilmot Matthews IND (83)
- Claude Ricks IND
- Eric Zwisler IND
- Last Annual
- September 30th, 2022
- Last Interim
- March 31st, 2023
- Incorporated
- September 11th, 2003
- Public Since
- February 9th, 2005
- No. of Employees
- 55
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 407,170,550
- Address
- 36 Meteor Dr, ETOBICOKE, M9W 1A4
- Web
- https://sqidiagnostics.com/
- Phone
- +1 4166749500
- Auditors
- RSM Canada LLP
Upcoming Events for SQD.H
Similar to SQD.H
Binovi Technologies
TSX Venture Exchange
Cloud DX
TSX Venture Exchange
H-Source Holdings
TSX Venture Exchange
Lattice Biologics
TSX Venture Exchange
Verisante Technology
TSX Venture Exchange
FAQ
As of Today at 22:24 UTC, shares in SQI Diagnostics are trading at CA$0.02. This share price information is delayed by 15 minutes.
Shares in SQI Diagnostics last closed at CA$0.02 and the price had moved by -91.43% over the past 365 days. In terms of relative price strength the SQI Diagnostics share price has underperformed the Toronto Stock Exchange 300 Composite Index by -92.72% over the past year.
There is no consensus recommendation for this security.
Find out moreSQI Diagnostics does not currently pay a dividend.
SQI Diagnostics does not currently pay a dividend.
SQI Diagnostics does not currently pay a dividend.
To buy shares in SQI Diagnostics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.02, shares in SQI Diagnostics had a market capitalisation of .
Here are the trading details for SQI Diagnostics:
- Country of listing: Canada
- Exchange: NEX
- Ticker Symbol: SQD.H
Based on an overall assessment of its quality, value and momentum SQI Diagnostics is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SQI Diagnostics. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -84.33%.
As of the last closing price of CA$0.02, shares in SQI Diagnostics were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SQI Diagnostics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
SQI Diagnostics' management team is headed by:
- Clive Beddoe - CEO
- Eric Brouwer - CSO
- Andrew Morris - DRC
- Gerald Connor - IND
- Wilmot Matthews - IND
- Claude Ricks - IND
- Eric Zwisler - IND